Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
428.6 USD | -0.31% | +4.54% | +5.40% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
10/05 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.40% | 11TCr | |
+12.13% | 11TCr | |
-12.61% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.82% | 1.7TCr | |
+5.15% | 1.37TCr | |
+37.63% | 1.24TCr | |
+289.71% | 797.79Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q3 2016 Earnings Call, Oct 25, 2016